VALIDATION OF A NOVEL CYTOMEGALOVIRUS-SPECIFIC ELISPOT ASSAY TO MONITOR THE FUNCTIONALITY OF CELL-MEDIATED IMMUNITY IN HEMODIALYSIS PATIENTS

被引:0
|
作者
Banas, B. [1 ]
Boeger, C. [1 ]
Lueckhoff, G. [2 ]
Krueger, B. [3 ]
Barabas, S. [4 ]
Starke, A. [4 ]
Schemmerer, M. [4 ]
Rascle, A. [4 ]
Koestler, J. [5 ]
Wagner, R. [4 ,5 ]
Deml, L. [4 ]
Leicht, J. [6 ]
Kraemer, B. [3 ]
机构
[1] Univ Med Ctr Regensburg, Dept Nephrol, Regensburg, Germany
[2] Dialysis Ctr Landshut, Landshut, Germany
[3] Univ Med Ctr Mannheim, Dept Med 5, Mannheim, Germany
[4] Lophius Biosci, Regensburg, Germany
[5] Univ Regensburg, Inst Med Microbiol & Hyg, Regensburg, Germany
[6] Dialysis Ctr Schwandorf, Schwandorf, Germany
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
PV005
引用
收藏
页码:20 / 20
页数:1
相关论文
共 50 条
  • [21] QuantiFERON®-CMV assay for the assessment of cytomegalovirus cell-mediated immunity
    Giulieri, Stefano
    Manuel, Oriol
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2011, 11 (01) : 17 - 25
  • [22] State-of-the-Art Monitoring of Cytomegalovirus-Specific Cell-Mediated Immunity After Organ Transplant: A Primer for the Clinician
    Egli, Adrian
    Humar, Atul
    Kumar, Deepali
    CLINICAL INFECTIOUS DISEASES, 2012, 55 (12) : 1678 - 1689
  • [23] Cytomegalovirus-specific cell-mediated immunity after prophylaxis predicts late-onset infection in lung transplantation
    Revilla Lopez, Eva
    Jarque, Marta
    Saez Gimenez, Berta
    Los Arcos, Ibai
    Gomez Olles, Susana
    Bestard, Oriol
    Bravo, Carlos
    Monforte, Victor
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [24] VALIDATION OF THE SUITABILITY OF LOPHIUS BIOSCIENCES T-TRACK® CMV TO ASSESS THE FUNCTIONALITY OF CELL-MEDIATED IMMUNITY (CMI) IN HEMODIALYSIS PATIENTS
    Banas, B.
    Boeger, C.
    Lueckhoff, G.
    Krueger, B.
    Starke, A.
    Bendfeldt, H.
    Batzilla, J.
    Schemmerer, M.
    Koestler, J.
    Barabas, S.
    Wagner, R.
    Deml, L.
    Leicht, J.
    Kraemer, B. K.
    TRANSPLANT INTERNATIONAL, 2014, 27 : 16 - 16
  • [25] Association of Cytomegalovirus-Specific T Cell-Mediated Immunity with the Risk of CMV Infection Occurrence in Kidney Transplant Recipients.
    Deborska-Materkowska, D.
    Perkowska-Ptasinska, A.
    Sadowska, A.
    Sitarek, D.
    Gozdowska, J.
    Ciszek, M.
    Serwanska-Swietek, M.
    Jozwik, A.
    Domagala, P.
    Kwiatkowski, A.
    Durlik, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 312 - 312
  • [26] Determination of Rubella Virus-Specific Cell-Mediated Immunity Using IFNγ-ELISpot
    Allmendinger, J.
    Paradies, F.
    Kamprad, M.
    Richter, T.
    Pustowoit, B.
    Liebert, U. G.
    JOURNAL OF MEDICAL VIROLOGY, 2010, 82 (02) : 335 - 340
  • [27] Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy
    Weinberg, A
    Wohl, DA
    Barrett, RJ
    van der Horst, C
    JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (06): : 707 - 712
  • [28] AN OPTIMIZED ELISPOT ASSAY TO DETERMINE CMV PROTEIN-REACTIVE CELLS OF CELL-MEDIATED IMMUNITY
    Barabas, Sascha
    Tonar, Charlotte
    Spindler, Theresa
    Widmann, Tamara
    Tudor, Silke
    Batzilla, Julia
    Deml, Ludwig
    Bendfeldt, Hanna
    TRANSPLANT INTERNATIONAL, 2015, 28 : 435 - 435
  • [29] AN OPTIMIZED ELISPOT ASSAY TO DETERMINE CMV PROTEIN-REACTIVE CELLS OF CELL-MEDIATED IMMUNITY
    Barabas, S.
    Spindler, T.
    Tonar, C.
    Widmann, T.
    Batzilla, J.
    Boeckl, K.
    Deml, L.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 17 - 18
  • [30] Effects of zinc on cell-mediated immunity in chronic hemodialysis patients
    Ribeiro, RCJ
    Sales, VSF
    Neves, FDR
    Drabe, S
    Brandao-Neto, J
    BIOLOGICAL TRACE ELEMENT RESEARCH, 2004, 98 (03) : 209 - 217